NCT06092580View on ClinicalTrials.gov

Phase 1 Study of AWT020 in Advanced Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Advanced Cancer
Interventions
BIOLOGICAL

AWT020

Participants receiving AWT020 once every two weeks or longer at designated dose levels

Trial Locations (4)

3168

RECRUITING

Monash Medical Centre, Clayton

4101

RECRUITING

ICON Cancer Center South Brisbane, South Brisbane

5042

RECRUITING

Southern Oncology Clinical Research Unit (SOCRU), Bedford Park

Unknown

RECRUITING

Alfred Health, Melbourne

Sponsors

Lead Sponsor

Anwita Biosciences
All Listed Sponsors
lead

Anwita Biosciences

INDUSTRY

NCT06092580 - Phase 1 Study of AWT020 in Advanced Cancer | Biotech Hunter | Biotech Hunter